The University Medical Center’s Founding Office is part of the inter-university founding office of the University, University of Applied Sciences and University Medical Centre Mainz with the objective of supporting founding-affine potentials from science and research and further developing academic founding events at the University Medical Centre Mainz. Through the active collaboration of the three academic locations, it is possible to fall back on the large founding network as well as existing expertise.
The highly qualified and committed team informs students, members of staff and alumni interested in founding and accompanies them on their way into hiving off enterprises, company/practice takeovers and independence.
The Founding Office offers the following range of services:
varied and diverse information on the topic of founding (hiving-off)
individual counselling and accompaniment for founding projects
support with the development of ideas
financing, promotion programmes and competitions
contacts to external co-operation partners and venture capital providers
functions on the topic of founding opportunities and their implementation
lecture and qualification
Your contact at the newly established Founding Office at the University Medical Center Mainz is Ms. Bettina Kollar (tel.: 06131 17-9705;gruendungsbuero(at)um.mainz.de, office hours: tuesday, 10.00h - 12.00h andby appointment).
founded by UMC-member: Univ.-Prof. Dr. U. Sahin
The institute for translational oncology (TRON), led as a gGmbH, undertakes a bridging position between science and health care. In the future, the University Medical Center’s research results should be efficiently incorporated into a new diagnostic procedure and pharmaceuticals or vaccines with the help of the institute. TRON’s scope of duties is fundamentals and application-oriented research work in the field of oncology and immunology.
founded by UMC-member: Univ.-Prof. Dr. C. Huber / Univ.-Prof. Dr. U. Sahin
BioNTech AG is a biotech company developing novel personalized immunotherapy approaches for cancer diagnostics and treatment.
Daughter companies of BioNTech AG :
Contact person at UMC: Ms. Döhn, Tel.: 06131 17-7237
Since 2008, the Medical Center is operating with the aim of improving treatment of patients by means of a multidisciplinary approach. The usage of shared resources and a multidisciplinary treatment on the campus of the UMC Mainz are central features of the Medical Center’s mode of operation. The range of services include the following specialties: gynecology, human genetics, neuropsychology, nuclear medicine, laboratory medicine, pathology, radiation therapy. The Medical Center is a 100 percent subsidiary of the University Medical Center Mainz, corporation under public law.
founded by UMC-members: Prof. Dr. Dr. H. Schröder / Univ.-Prof. W. E. G. Müller
The NanotecMARIN GmbH was founded in 2007 as a spin-off of the BMBF excellence center via marine biotechnology (“BIOTECmarin”) and is located on campus of Mainz University. The company’s purpose is the development and commercialization of biomaterials and bioactive substances from marine sources for biomedical application, in particular in the field of bone diseases and dentistry. The company has several patents in the area of nanobiotechnology and biomedicine. It also participates in several EU projects with the University Medical Center Mainz.
founded by UMC-member: Prof. Dr. T. W. Vomweg
CADMEI GmbH is a software company specialized to Computer Diagnosis in Medical Images.
co-founded by UMC-member: Univ.-Prof. Dr. A. Maelicke
The Galantos GmbH is a biopharmaceutical company which focuses on research and development of medication for the treatment of degenerative diseases of the human brain. This includes Alzheimer’s dementia (AD) in particular.
founded by UMC-member: Univ.-Prof. Dr. M. Tchirikov
founded by UMC-member: Prof. Dr. M. Maeurer
The leading task of THYMED GmbH is the application and development of new and medical-relevant test systems for the acquirement of new insights regarding immune function of infectious diseases, tumors, and autoimmunity.
co-founded by UMC-member: Univ.-Prof. Dr. C. von Eichel-Streber
The company's remit deals with the usage of bacteria for development and production of innovative bio-pharmaceuticals. With the platform technology of bacterial gen shuttles, the surface changing tgcBacteria, and the tgcBasteria as an innovative gram-positive expression system, the company has unique opportunities of the application of modern Molecular Biology.
As the only institute of pathology worldwide, the Center for rheumatic pathology exclusively works in the field of rheumatic diseases. Through morphological analysis it is their goal to uncover pathogenetic mechanisms, which underlie rheumatic diseases, in order to enable a therapy-optimized diagnostics. Through close cooperation with numerous clinics and orthopedist in private practice worldwide, which send tissue samples for diagnosis, the diagnostic statements are being specified regularly.